What's Happening?
A yearlong review of approximately 17,500 local expenditures, conducted by KFF Health News in collaboration with the Johns Hopkins Bloomberg School of Public Health and Shatterproof, has revealed that a significant portion of opioid settlement funds in 2025
was spent on items with tenuous links to addiction. Examples include $36,200 for a pickleball court in Gilmer County, West Virginia, and $130,000 for license-plate cameras in Carmel, Indiana. State and local governments spent or committed about $3.7 billion in settlement funds that year. The review found that critical programs, such as syringe service programs and services for babies exposed to drugs in the womb, each received less than 1% of the nationwide spending. The settlements, expected to total around $60 billion over nearly two decades, mandate that at least 85% of the funds going directly to participating states and local governments must address the opioid epidemic.
Why It's Important?
The misallocation of opioid settlement funds has significant implications for public health and accountability in the U.S. The primary purpose of these settlements was to mitigate the harm caused by the opioid epidemic, which continues to devastate communities. Diverting funds to unrelated projects undermines the intended impact of these settlements, potentially prolonging the crisis and failing to provide essential support to those most affected. Families who have lost loved ones to overdose are particularly vocal about the need for these funds to be used effectively. The lack of stringent oversight in some states, where guidelines are advisory rather than enforceable, allows for such questionable spending, raising concerns about transparency and the efficient use of public resources intended for a critical national health crisis.
What's Next?
The findings of this review are likely to intensify scrutiny on how state and local governments manage opioid settlement funds. There may be increased pressure from advocacy groups and the public for stricter oversight mechanisms and clearer guidelines for permissible expenditures. Residents are encouraged to monitor their local government's spending through state dashboards and public meetings, and to advocate for the inclusion of individuals in recovery and family members on opioid advisory committees. While the settlements are paid out over many years, allowing for future adjustments, the current revelations highlight an urgent need for reform to ensure that the remaining funds are directed towards evidence-based addiction treatment, prevention, and recovery services. MedicalDaily will continue to track how states respond to this review and whether rules are tightened.
Beyond the Headlines
Beyond the immediate financial implications, this issue touches upon broader themes of governance, public trust, and the effectiveness of large-scale public health initiatives. The varied approaches to oversight across states expose systemic weaknesses in accountability when significant funds are disbursed to numerous local entities. It also highlights a potential disconnect between the stated goals of national settlements and their implementation at the local level, where priorities may diverge. The debate over what constitutes an appropriate use of these funds—such as the inclusion of defibrillators for overdose response—underscores the complexity of addressing a multifaceted crisis like the opioid epidemic and the need for expert-informed decision-making rather than ad-hoc spending.
